Lipella Pharms Inc (LIPO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2021 | 12-2020 | |
| Assets | ||
| Current Assets | ||
| Cash & Cash Equivalents | 1,414 | 607 |
| Marketable Securities | 301 | 0 |
| Receivables | 0 | 69 |
| Other current assets | 93 | 23 |
| TOTAL | $1,808 | $699 |
| Non-Current Assets | ||
| TOTAL | $N/A | $N/A |
| Total Assets | $2,013 | $955 |
| Liabilities | ||
| Current Liabilities | ||
| Short Term Debt | 25 | 78 |
| Accounts payable and accrued liabilities | 47 | 25 |
| Accrued Expenses | 152 | 0 |
| Other current liabilities | 78 | 52 |
| TOTAL | $341 | $208 |
| Non-Current Liabilities | ||
| Long Term Debt | 50 | 50 |
| Other Non-Current Liabilities | 30 | 26 |
| TOTAL | $80 | $76 |
| Total Liabilities | $589 | $492 |
| Shareholders' Equity | ||
| Common Shares | 1 | 1 |
| Retained earnings | -3,107 | -1,242 |
| TOTAL | $1,424 | $463 |
| Total Liabilities And Equity | $2,013 | $955 |